Early research (Phase 1)Study completedNCT04510987
What this trial is testing
Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")
Who this might be right for
Prevention of Thromboembolic Events
Bayer 48